论文部分内容阅读
2013年5月,奥地利科学家研究出新方法,利用含免疫调节物质咪喹莫特的栓剂治疗早期宫颈癌,在临床试验中取得了较好的效果。该方法由维也纳综合癌症中心开发,试验显示它对二级到三级的宫颈上皮内瘤变有明显疗效,肿瘤的缓解率可达69%。人乳头瘤病毒感染能引发宫颈上皮内瘤变,进而导致宫颈癌。对于二级到三级的中度和重度癌变,通常的治疗措施是切除一部分宫颈组织。
In May 2013, Austrian scientists developed new methods to treat early cervical cancer with suppositories containing imiquimod, an immunomodulatory substance, and achieved good results in clinical trials. The method developed by the Vienna Comprehensive Cancer Center, the test showed that it has two to three cervical intraepithelial neoplasia significant effect, the tumor response rate was 69%. Human papillomavirus infection can cause cervical intraepithelial neoplasia, leading to cervical cancer. For secondary and tertiary levels of moderate and severe cancer, the usual treatment is to remove part of the cervical tissue.